MiR-186 Inhibited Migration of NSCLC via Targeting cdc42 and Effecting EMT Process

被引：34
|
作者：
Dong, Ying [1 ]
Jin, Xintian [2 ]
Sun, Zhiqiang [3 ]
Zhao, Yueming [4 ]
Song, Xianjing [5 ]
机构：
[1] Tumor Hosp Jilin Prov, Dept Radiotherapy, Changchun 130021, Peoples R China
[2] Tumor Hosp Jilin Prov, Dept Thorac, Changchun 130021, Peoples R China
[3] Tumor Hosp Jilin Prov, Dept Invas Technol, Changchun 130021, Peoples R China
[4] Tumor Hosp Jilin Prov, Dept Oncol, Changchun 130021, Peoples R China
[5] Jilin Univ, Hosp 2, Dept Cardiol, Changchun 130041, Peoples R China
来源：
MOLECULES AND CELLS | 2017年 / 40卷 / 03期
关键词：
cdc42; EMT; migration; MiR-186; NSCLC; CELL-PROLIFERATION; 3RD-LINE TREATMENT; CANCER; EXPRESSION; MICRORNAS; INVASION; MIR-B-10;
D O I：
10.14348/molcells.2017.2291
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
In this study, qRT-PCR was employed to identify that miR-186 expression level in NSCLC tissues are highly associated with lymph node metastasis. In addition, through the application of western blotting, luciferase assay and qRT-PCR, it was found that miR-186 targeted 3. UTR of cdc42 mRNA and down-regulated cdc42 protein level in a post-transcriptional manner. Transwell assay indicated that cdc42 partially reversed the effect of miR-186 mimics. Besides, miR-186 was proved to regulate EMT by influencing biomarkers of this process and cell adhesion ability. Thus, miR-186 is a potential target for NSCLC therapy. miR-186 is proposed to be one of tumor-suppressors and may serve as a therapeutic target in NSCLC treatment.
引用
收藏
页码：195 / 201
页数：7
相关论文
共 50 条
  • [21] miR-186 inhibits proliferation, migration, and epithelial-mesenchymal transition in breast cancer cells by targeting Twist1
    Sun, Wen-juan
    Zhang, Ya-na
    Xue, Peng
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (06) : 10001 - 10009
  • [22] Deletion of miR-15a inhibited glioma development via targeting Smad7 and inhibiting EMT pathway
    Guo, Yanfeng
    Gao, Xiaopeng
    An, Shien
    Li, Xin
    Pan, Lekun
    Liu, Hongyan
    Liu, Jixiang
    Gao, Jianzhou
    Zhao, Zhihuang
    Li, Gang
    Han, Yonggang
    Li, Yabin
    Ji, Zhisheng
    AGING-US, 2021, 13 (21): : 24339 - 24348
  • [23] MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42
    Chou, Jinjiang
    Wang, Bingyu
    Zheng, Tianjing
    Li, Xiaoman
    Zheng, Lufeng
    Hu, Jinhang
    Zhang, Yan
    Xing, Yingying
    Xi, Tao
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 472 (01) : 262 - 269
  • [24] MiR-126-3p suppresses the growth, migration and invasion of NSCLC via targeting CCR1
    Liu, R.
    Zhang, Y-S
    Zhang, S.
    Cheng, Z-M
    Yu, J-L
    Zhou, S.
    Song, J.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (02) : 679 - 689
  • [25] LncRNA-H19 activates CDC42/PAK1 pathway to promote cell proliferation, migration and invasion by targeting miR-15b in hepatocellular carcinoma
    Zhou, Yong
    Fan, Ren-Gen
    Qin, Cheng-Lin
    Jia, Jing
    Wu, Xu-Dong
    Zha, Wen-Zhang
    GENOMICS, 2019, 111 (06) : 1862 - 1872
  • [26] miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patients
    Cuijuan Shi
    Linlin Ren
    Cuiyun Sun
    Lin Yu
    Xiuwu Bian
    Xuexia Zhou
    Yanjun Wen
    Dan Hua
    Shujun Zhao
    Wenjun Luo
    Run Wang
    Chun Rao
    Qian Wang
    Shizhu Yu
    British Journal of Cancer, 2017, 117 : 1036 - 1047
  • [27] Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42
    Yang, Tian
    Chen, Tianjun
    Li, Yang
    Gao, Lei
    Zhang, Shuo
    Wang, Ting
    Chen, Mingwei
    TUMOR BIOLOGY, 2015, 36 (03) : 1903 - 1911
  • [28] miR-17 is involved in Japanese Flounder (Paralichthys olivaceus) development by targeting the Cdc42 mRNA
    Zhang, Hongmei
    Fu, Yuanshuai
    Shi, Zhiyi
    Su, Yanfang
    Zhang, Junling
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 2016, 191 : 163 - 170
  • [29] Downregulation of circRNA_100876 Inhibited Progression of NSCLC In Vitro via Targeting miR-636
    Song, Jianxiang
    Shi, Woda
    Gao, Zhengya
    Liu, Xingchen
    Wang, Wencai
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [30] miR-485-5p suppresses Schwann cell proliferation and myelination by targeting cdc42 and Rac1
    Zhang, Zhan
    Li, Xuyang
    Li, Aipeng
    Wu, Guangzhi
    EXPERIMENTAL CELL RESEARCH, 2020, 388 (01)
12345